{"id":45313,"date":"2025-04-24T01:18:28","date_gmt":"2025-04-24T01:18:28","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/45313\/"},"modified":"2025-04-24T01:18:28","modified_gmt":"2025-04-24T01:18:28","slug":"argent-biopharma-enters-germany-europes-largest-market-2","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/45313\/","title":{"rendered":"Argent BioPharma Enters Germany &#8211; Europe&#8217;s Largest Market"},"content":{"rendered":"<ul>\n<li>Argent BioPharma (ASX: RGT, OTCQB: RGTLF) enters Germany, Europe&#8217;s largest healthcare market, securing initial purchase orders for CannEpil\u00ae and CogniCann\u00ae.<\/li>\n<li>Operational restructuring through the transfer of EU GMP-certified manufacturing facilities is expected to save over $1 million annually.<\/li>\n<li>Cost savings will be redirected to accelerate R&amp;D and clinical trials across core therapeutic programs.<\/li>\n<\/ul>\n<p>Argent BioPharma Ltd. (ASX: RGT, OTCQB: RGTLF), a clinical-stage biopharmaceutical company, has announced a significant milestone with its entry into the German pharmaceutical market. The company has secured initial purchase orders for its neuroimmune therapies CannEpil\u00ae and CogniCann\u00ae, following regulatory approval, marking a pivotal step in its European expansion strategy.<\/p>\n<p>Germany represents a strategic commercial opportunity for Argent, being the largest healthcare market in Europe. The successful penetration into this market highlights the company&#8217;s intention to deepen its reach across high-value regions.<\/p>\n<p>Additionally, Argent BioPharma has completed the transfer of its EU GMP-certified manufacturing facilities located in Slovenia and Malta to third-party operators. This strategic operational shift is anticipated to generate annual cost savings exceeding $1 million while maintaining GMP compliance. The cost efficiencies gained will be pivotal in accelerating research and development initiatives and advancing clinical trials across Argent&#8217;s therapeutic programs.<\/p>\n<p>These developments underscore Argent BioPharma&#8217;s commitment to a transformative strategy focused on proprietary neuroimmune drug development and sustainable global expansion.<\/p>\n","protected":false},"excerpt":{"rendered":"Argent BioPharma (ASX: RGT, OTCQB: RGTLF) enters Germany, Europe&#8217;s largest healthcare market, securing initial purchase orders for CannEpil\u00ae&hellip;\n","protected":false},"author":2,"featured_media":45314,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5310],"tags":[3907,2000,299,1824,12948,12949,12,24943],"class_list":{"0":"post-45313","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-germany","8":"tag-article","9":"tag-eu","10":"tag-europe","11":"tag-germany","12":"tag-gurufocus","13":"tag-gurufocus-news","14":"tag-news","15":"tag-rgtlf"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/114390309556026867","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/45313","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=45313"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/45313\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/45314"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=45313"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=45313"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=45313"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}